Toca­gen stream­lines piv­otal plans; Wave Life Sci­ences cuts rib­bon on new man­u­fac­tur­ing plant

→ San Diego-based Toca­gen $TO­CA has stream­lined its Phase III plans for To­ca 511 & To­ca FC as a new ther­a­py for brain can­cer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland